KR101133785B1 - Composition for Preventing Hair Loss and Promoting Hair Growth Containing Scultellaria baicallensis and Method of Preparing the Same - Google Patents
Composition for Preventing Hair Loss and Promoting Hair Growth Containing Scultellaria baicallensis and Method of Preparing the Same Download PDFInfo
- Publication number
- KR101133785B1 KR101133785B1 KR1020090064244A KR20090064244A KR101133785B1 KR 101133785 B1 KR101133785 B1 KR 101133785B1 KR 1020090064244 A KR1020090064244 A KR 1020090064244A KR 20090064244 A KR20090064244 A KR 20090064244A KR 101133785 B1 KR101133785 B1 KR 101133785B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- composition
- hair loss
- distillate
- hot water
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 85
- 230000003658 preventing hair loss Effects 0.000 title claims abstract description 43
- 230000001737 promoting effect Effects 0.000 title claims abstract description 35
- 230000003779 hair growth Effects 0.000 title description 11
- 238000000034 method Methods 0.000 title description 8
- 239000000284 extract Substances 0.000 claims abstract description 101
- 210000002268 wool Anatomy 0.000 claims abstract description 37
- 239000010865 sewage Substances 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- 244000194101 Ginkgo biloba Species 0.000 claims description 21
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 21
- 241000218691 Cupressaceae Species 0.000 claims description 17
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 17
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 16
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 16
- 229940010454 licorice Drugs 0.000 claims description 16
- 241000202807 Glycyrrhiza Species 0.000 claims description 15
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 11
- 235000008434 ginseng Nutrition 0.000 claims description 11
- 235000011201 Ginkgo Nutrition 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000004821 distillation Methods 0.000 claims description 2
- 241000208340 Araliaceae Species 0.000 claims 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims 1
- 241000195493 Cryptophyta Species 0.000 claims 1
- 235000011941 Tilia x europaea Nutrition 0.000 claims 1
- 239000004571 lime Substances 0.000 claims 1
- 210000004209 hair Anatomy 0.000 abstract description 37
- 230000000694 effects Effects 0.000 abstract description 27
- 235000002789 Panax ginseng Nutrition 0.000 abstract description 21
- 210000004761 scalp Anatomy 0.000 abstract description 21
- 239000009429 Ginkgo biloba extract Substances 0.000 abstract description 15
- 229940068052 ginkgo biloba extract Drugs 0.000 abstract description 13
- 235000020686 ginkgo biloba extract Nutrition 0.000 abstract description 13
- 229940069445 licorice extract Drugs 0.000 abstract description 13
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 229940107588 barberry extract Drugs 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 229930014626 natural product Natural products 0.000 abstract description 6
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 201000004384 Alopecia Diseases 0.000 description 21
- 230000003676 hair loss Effects 0.000 description 20
- 208000024963 hair loss Diseases 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- -1 gold Natural products 0.000 description 17
- 240000000724 Berberis vulgaris Species 0.000 description 10
- 235000016068 Berberis vulgaris Nutrition 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 10
- 230000003078 antioxidant effect Effects 0.000 description 10
- 240000004371 Panax ginseng Species 0.000 description 9
- 239000003963 antioxidant agent Substances 0.000 description 9
- 235000006708 antioxidants Nutrition 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 230000006872 improvement Effects 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 229930003935 flavonoid Natural products 0.000 description 7
- 235000017173 flavonoids Nutrition 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 238000003809 water extraction Methods 0.000 description 7
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 6
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 150000002215 flavonoids Chemical class 0.000 description 6
- 210000003780 hair follicle Anatomy 0.000 description 6
- 229960003632 minoxidil Drugs 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 239000002453 shampoo Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 4
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229930182470 glycoside Natural products 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 208000001840 Dandruff Diseases 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000003266 anti-allergic effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- 229960001285 quercetin Drugs 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 description 2
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- IWEIJEPIYMAGTH-UHFFFAOYSA-N Bilobetin Chemical compound COC1=CC=C(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)C=C1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 IWEIJEPIYMAGTH-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- MVMVWNMQGBYIDM-UHFFFAOYSA-N Cyclobrassinin Chemical compound N1C2=CC=CC=C2C2=C1SC(SC)=NC2 MVMVWNMQGBYIDM-UHFFFAOYSA-N 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- LHXDLQBQYFFVNW-UHFFFAOYSA-N Fenchone Chemical compound C1CC2(C)C(=O)C(C)(C)C1C2 LHXDLQBQYFFVNW-UHFFFAOYSA-N 0.000 description 2
- SQGLUEWZRKIEGS-UHFFFAOYSA-N Ginkgetin Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 SQGLUEWZRKIEGS-UHFFFAOYSA-N 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 2
- YKGCBLWILMDSAV-GOSISDBHSA-N Isoxanthohumol Natural products O(C)c1c2C(=O)C[C@H](c3ccc(O)cc3)Oc2c(C/C=C(\C)/C)c(O)c1 YKGCBLWILMDSAV-GOSISDBHSA-N 0.000 description 2
- 229930045534 Me ester-Cyclohexaneundecanoic acid Natural products 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- 238000001604 Rao's score test Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- QYKQWFZDEDFELK-UHFFFAOYSA-N brassinin Chemical compound C1=CC=C2C(CNC(=S)SC)=CNC2=C1 QYKQWFZDEDFELK-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 2
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 2
- 235000011957 flavonols Nutrition 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- AIFCFBUSLAEIBR-UHFFFAOYSA-N ginkgetin Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C(C=1)=CC=C(OC)C=1C1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 AIFCFBUSLAEIBR-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000031774 hair cycle Effects 0.000 description 2
- 239000012676 herbal extract Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000001361 intraarterial administration Methods 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 2
- 235000008800 isorhamnetin Nutrition 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 210000002445 nipple Anatomy 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- YCXRBCHEOFVYEN-UHFFFAOYSA-N sciadopitysin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C(C=3C(=CC=C(C=3)C=3OC4=CC(OC)=CC(O)=C4C(=O)C=3)OC)=C2O1 YCXRBCHEOFVYEN-UHFFFAOYSA-N 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229940043810 zinc pyrithione Drugs 0.000 description 2
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 2
- GRWFGVWFFZKLTI-UHFFFAOYSA-N α-pinene Chemical compound CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 2
- LHXDLQBQYFFVNW-XCBNKYQSSA-N (+)-Fenchone Natural products C1C[C@]2(C)C(=O)C(C)(C)[C@H]1C2 LHXDLQBQYFFVNW-XCBNKYQSSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- FAMPSKZZVDUYOS-OWEBEESNSA-N (1e,4z,8e)-2,6,6,9-tetramethylcycloundeca-1,4,8-triene Chemical compound C\C1=C/CC(C)(C)\C=C/C\C(C)=C\CC1 FAMPSKZZVDUYOS-OWEBEESNSA-N 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 229930182836 (R)-noradrenaline Natural products 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- PHZOWSSBXJXFOR-UHFFFAOYSA-N 2-Propenyl glucosinolate Natural products OCC1OC(SC(CC=C)=NOS(O)(=O)=O)C(O)C(O)C1O PHZOWSSBXJXFOR-UHFFFAOYSA-N 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N 3‐isothujone Chemical compound CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- 125000000972 4,5-dimethylthiazol-2-yl group Chemical group [H]C([H])([H])C1=C(N=C(*)S1)C([H])([H])[H] 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- OZKVQSNRAFPWMK-ZXNPVPFQSA-N 8-(Methylsulfonyl)octyl glucosinolate Natural products S(=O)(=O)(O/N=C(/S[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](CO)O1)\CCCCCCCCS(=O)(=O)C)O OZKVQSNRAFPWMK-ZXNPVPFQSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- PYIXHKGTJKCVBJ-UHFFFAOYSA-N Astraciceran Natural products C1OC2=CC(O)=CC=C2CC1C1=CC(OCO2)=C2C=C1OC PYIXHKGTJKCVBJ-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- FXNFHKRTJBSTCS-UHFFFAOYSA-N Baicalein Natural products C=1C(=O)C=2C(O)=C(O)C(O)=CC=2OC=1C1=CC=CC=C1 FXNFHKRTJBSTCS-UHFFFAOYSA-N 0.000 description 1
- NDVRQFZUJRMKKP-UHFFFAOYSA-N Betavulgarin Natural products O=C1C=2C(OC)=C3OCOC3=CC=2OC=C1C1=CC=CC=C1O NDVRQFZUJRMKKP-UHFFFAOYSA-N 0.000 description 1
- MOLPUWBMSBJXER-YDGSQGCISA-N Bilobalide Natural products O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 description 1
- 244000178993 Brassica juncea Species 0.000 description 1
- 235000011332 Brassica juncea Nutrition 0.000 description 1
- 235000014700 Brassica juncea var napiformis Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000587240 Cynanchum Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000035859 Drug effect increased Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 208000021129 Postpartum disease Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- PHZOWSSBXJXFOR-MYMDCHNCSA-N Sinigrin Natural products S(=O)(=O)(O/N=C(\S[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)/CC=C)O PHZOWSSBXJXFOR-MYMDCHNCSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- HIMJIPRMECETLJ-UHFFFAOYSA-N Wogonin Natural products COc1cc(O)c(O)c2C(=O)C=C(Oc12)c3ccccc3 HIMJIPRMECETLJ-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- PTHYCBGWNSSYAV-UHFFFAOYSA-N acetic acid;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid Chemical compound CC(O)=O.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O PTHYCBGWNSSYAV-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- HITDPRAEYNISJU-UHFFFAOYSA-N amenthoflavone Natural products Oc1ccc(cc1)C2=COc3c(C2=O)c(O)cc(O)c3c4cc(ccc4O)C5=COc6cc(O)cc(O)c6C5=O HITDPRAEYNISJU-UHFFFAOYSA-N 0.000 description 1
- YUSWMAULDXZHPY-UHFFFAOYSA-N amentoflavone Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)O)=C2O1 YUSWMAULDXZHPY-UHFFFAOYSA-N 0.000 description 1
- HVSKSWBOHPRSBD-UHFFFAOYSA-N amentoflavone Natural products Oc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)c(c3O2)c4cc(ccc4O)C5=COc6cc(O)cc(O)c6C5=O HVSKSWBOHPRSBD-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 1
- 229940063953 ammonium lauryl sulfate Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 102000001307 androgen receptors Human genes 0.000 description 1
- 108010080146 androgen receptors Proteins 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003656 anti-hair-loss Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940089116 arnica extract Drugs 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- ZWXYEWJNBYQXLK-UHFFFAOYSA-N azanium;4-dodecoxy-4-oxo-3-sulfobutanoate Chemical compound [NH4+].CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC([O-])=O ZWXYEWJNBYQXLK-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- UDFLTIRFTXWNJO-UHFFFAOYSA-N baicalein Chemical compound O1C2=CC(=O)C(O)=C(O)C2=C(O)C=C1C1=CC=CC=C1 UDFLTIRFTXWNJO-UHFFFAOYSA-N 0.000 description 1
- 229940015301 baicalein Drugs 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- 229940069780 barley extract Drugs 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 235000007215 black sesame Nutrition 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- FUSADYLVRMROPL-UHFFFAOYSA-N demethylxanthohumol Natural products CC(C)=CCC1=C(O)C=C(O)C(C(=O)C=CC=2C=CC(O)=CC=2)=C1O FUSADYLVRMROPL-UHFFFAOYSA-N 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 229930006735 fenchone Natural products 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 229930184727 ginkgolide Natural products 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000009583 hair follicle growth Effects 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- WTDHMFBJQJSTMH-UHFFFAOYSA-N hinokiflavone Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C(OC=3C=CC(=CC=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)=C(O)C=C2O1 WTDHMFBJQJSTMH-UHFFFAOYSA-N 0.000 description 1
- HLFVFEBKCLAGBY-UHFFFAOYSA-N hinokiflavone Natural products Oc1ccc(cc1)C2=COc3cc(O)c(Oc4ccc(cc4)C5=CC(=O)c6c(O)cc(O)cc6O5)c(O)c3C2=O HLFVFEBKCLAGBY-UHFFFAOYSA-N 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- QBNFBHXQESNSNP-UHFFFAOYSA-N humulene Natural products CC1=CC=CC(C)(C)CC=C(/C)CCC1 QBNFBHXQESNSNP-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- HUOOMAOYXQFIDQ-UHFFFAOYSA-N isoginkgetin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C(C=3C(=CC=C(C=3)C=3OC4=CC(O)=CC(O)=C4C(=O)C=3)OC)=C2O1 HUOOMAOYXQFIDQ-UHFFFAOYSA-N 0.000 description 1
- CGPVRBMMGYBFAC-UHFFFAOYSA-N isoginkgetin Natural products COc1ccc(cc1)C2=COc3c(C2=O)c(O)cc(O)c3c4cc(ccc4OC)C5=CC(=O)c6c(O)cc(O)cc6O5 CGPVRBMMGYBFAC-UHFFFAOYSA-N 0.000 description 1
- YKGCBLWILMDSAV-SFHVURJKSA-N isoxanthohumol Chemical compound C1([C@H]2OC=3C(CC=C(C)C)=C(O)C=C(C=3C(=O)C2)OC)=CC=C(O)C=C1 YKGCBLWILMDSAV-SFHVURJKSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229940042472 mineral oil Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000280 phytoalexin Substances 0.000 description 1
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- NQJGJBLOXXIGHL-UHFFFAOYSA-N podocarpusflavone A Natural products COc1ccc(cc1)C2=CC(=O)c3c(O)cc(O)c(c3O2)c4cc(ccc4O)C5=COc6cc(O)cc(O)c6C5=O NQJGJBLOXXIGHL-UHFFFAOYSA-N 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- QKFAFSGJTMHRRY-OCFLFPRFSA-M potassium;[(e)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylbut-3-enylideneamino] sulfate Chemical compound [K+].OC[C@H]1O[C@@H](S\C(CC=C)=N\OS([O-])(=O)=O)[C@H](O)[C@@H](O)[C@@H]1O QKFAFSGJTMHRRY-OCFLFPRFSA-M 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229940117382 propecia Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 235000017291 sinigrin Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- VXQYICLHHMETFH-UHFFFAOYSA-N tetra-O-methylamentoflavone Natural products C1=CC(OC)=CC=C1C1=CC(=O)C2=C(O)C=C(OC)C(C=3C(=CC=C(C=3)C=3OC4=CC(OC)=CC(O)=C4C(=O)C=3)OC)=C2O1 VXQYICLHHMETFH-UHFFFAOYSA-N 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- 229930007110 thujone Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- XLTFNNCXVBYBSX-UHFFFAOYSA-N wogonin Chemical compound COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 XLTFNNCXVBYBSX-UHFFFAOYSA-N 0.000 description 1
- ORXQGKIUCDPEAJ-YRNVUSSQSA-N xanthohumol Chemical compound COC1=CC(O)=C(CC=C(C)C)C(O)=C1C(=O)\C=C\C1=CC=C(O)C=C1 ORXQGKIUCDPEAJ-YRNVUSSQSA-N 0.000 description 1
- UVBDKJHYMQEAQV-UHFFFAOYSA-N xanthohumol Natural products OC1=C(CC=C(C)C)C(OC)=CC(OC)=C1C(=O)C=CC1=CC=C(O)C=C1 UVBDKJHYMQEAQV-UHFFFAOYSA-N 0.000 description 1
- 235000008209 xanthohumol Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/002—Preparations for repairing the hair, e.g. hair cure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Neurosurgery (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 황금을 함유한 탈모 예방 및 양모 촉진용 조성물 및 그 제조방법에 관한 것으로, 더욱 상세하게는, 황금 추출물, 하수오 추출물, 개자 추출물, 마치현 추출물, 은행잎 추출물, 측백엽 추출물, 고삼 추출물 및 감초 추출물을 함유하는 탈모 예방 및 양모 촉진용 조성물에 관한 것이다.The present invention relates to a composition for preventing hair loss and wool promotion and a method for producing the same, and more specifically, golden extract, sewage extract, barberry extract, machiko extract, ginkgo biloba extract, white leaf extract, red ginseng extract and licorice extract It relates to a composition for preventing hair loss and promoting wool containing.
본 발명에 따른 탈모 예방 및 양모 촉진용 조성물은 천연물로 이루어져 인체에 부작용이 없으며, 모근 세포로의 원활한 혈액 순환 뿐만 아니라, 두피보호 및 모발의 영양 공급 기능까지 있어 탈모 예방 및 양모 촉진에 탁월한 효과가 있다.Hair loss prevention and wool promotion composition according to the present invention is made of natural products have no side effects to the human body, as well as smooth blood circulation to the hair root cells, scalp protection and hair nourishment function has excellent effects in preventing hair loss and promoting wool have.
Description
본 발명은 황금을 함유한 탈모 예방 및 양모 촉진용 조성물 및 그 제조방법에 관한 것이다.The present invention relates to a composition for preventing hair loss and promoting wool containing gold and a method for producing the same.
모발은 외부의 자극으로부터 완충작용과 자외선, 온도, 마찰 등 외부 자극으로부터 인체를 방어와 보호 작용을 하며, 신체에 불필요한 비소, 수은, 아연 등의 중금속을 흡수하여 체외로 배출하는 기능을 가지고 있으며, 외적 이미지 표현에 중요한 미적요소가 된다.Hair protects and protects the body from external stimuli such as buffering and external stimuli such as ultraviolet rays, temperature, and friction, and absorbs heavy metals such as arsenic, mercury, and zinc that are unnecessary to the body and releases them to the body. It is an important aesthetic factor in the expression of external images.
현대 사회에 들어 각종 스트레스와 환경오염, 약물 중독 및 오남용 등으로 인한 부작용, 파마, 염색, 정발제류의 사용과 유전적인 요인 등, 신체적, 정신적, 유전적, 환경적 등 여러 가지 원인으로 신체적 리듬이 깨져 밸런스가 맞지 않아 두피 뿐만 아니라 모낭도 크게 영향을 받고 있으며, 이로 인한 모발손상 뿐만 아니라, 건조하거나 민감해져, 탈모 등 여러 형태로 나타나고 있다.In modern society, physical rhythm is caused by various causes such as physical, mental, genetic, and environmental factors such as side effects from stress, environmental pollution, drug addiction and misuse, perm, dyeing, use of hair dressings and genetic factors. It is broken and unbalanced, not only the scalp but also hair follicles are greatly affected, resulting in various forms such as hair loss as well as dry or sensitive hair loss.
현재 알려진 탈모의 원인은 매우 여러 가지 요인에 의해 발생되는 것으로, 먼저 남성호르몬의 영향으로서 유전적인 요인에 따른 호르몬 과다 분비로 남성호르몬인 테스토스테론이 모포에서 활성이 높은 DHT(5알파-디하이드로 테스토스테론)로 변환되어 이 DHT가 안드로겐 수용체와 결합하여 모낭세포의 단백질 합성을 지연시켜 모낭의 생장기가 단축되고 모낭을 위축시켜 탈모를 유발시키거나, 또는 유두피에 공급되는 혈액순환 이상으로서 모포 및 모유두를 싸고 있는 말초 모세혈관의 혈류량이 감소하여 모유두 부위와 기저세포로 영양물질이 부족하게 되면 신진대사가 저하되어 모발 성장에 이상을 일으키게 되거나, 두피 생리기능 저하로서 비듬이 많이 생기면 모발의 표피 출구인 모구가 막히고 세균번식에 의해 두피가려움증, 염증 수반으로 탈모가 발생되거나, 두피긴장에 의한 국소 혈류장애로 두부 피하조직 말초 혈관의 혈류량 감소에 의해 모발 성장에 이상을 일으킴으로써 탈모가 발생되거나, 기타 영양부족, 약물에 의한 부작용, 유전, 스트레스, 환경적인 요인 등 여러 가지요인에 의해서 탈모가 유발되는 것으로 알려져 있다.Currently, the cause of hair loss is caused by a number of factors. First, male hormone testosterone, DHT (5 alpha-dihydrotestosterone), is highly active in the hair follicle due to the overproduction of hormones by genetic factors. DHT binds to androgen receptors to slow down the hair follicle protein synthesis, shorten hair follicle growth and shrink hair follicles to cause hair loss, or to cover hair follicles and nipples as an abnormal blood circulation supplied to the nipples If the amount of peripheral capillaries in the blood flow decreases and the nutrients are insufficient in the area of the papilla and basal cells, metabolism is reduced, causing hair growth abnormalities, or if dandruff occurs due to a decrease in physiological function of the scalp, Hair loss due to itching and inflammation of the scalp due to clogging and bacterial propagation Or hair loss due to abnormal blood growth caused by decreased blood flow in the peripheral blood vessels of the subcutaneous tissue of the head due to tension of the scalp, or other malnutrition, adverse effects caused by drugs, heredity, stress, environmental factors, etc. Hair loss is known to be caused by various factors.
현재 모발관리에 많은 관심이 집중되면서 상기와 같은 탈모발생 등을 예방하기 위하여 피부에 자극이 없고 부작용이 적은 천연추출물(생약재 추출물)을 이용하여 제조되는 화장료 조성물에 관한 연구와 발명이 활발히 진행되어, 탈모 방지나 양모, 발모 촉진용 조성물에 관한 특허 출원으로써, 가시오가피, 송엽, 송화, 교맥, 생지황 및 지모를 함유하는 생약 추출물을 함유하는 탈모방지 조성물 (대한민국특허공개 제10-2009-0051586호), 백두옹, 대산, 황금 추출물을 함유하는 모낭충 살균기능을 가지는 발모촉진조성물 등과 같이 천연물을 이용한 탈모 방지 조성물(대한민국특허출원공개 제10-2005-0014473호) 등 다수 특허출원이 존재하고 있다. 이러한 활발한 연구에 힘입어, 탈모예방을 위한 헤어로션, 헤어샴푸, 헤어트리트먼트, 헤어린스 등의 각종 화장료 조성물들이 다양하게 시중에 유통되어 사용되고 있으나, 통상적으로 유통되고 있는 종래의 화장료 조성물들은 실질적으로 비듬방지 및 탈모예방에 만족스러운 효과를 지닌 제품이 없고 각종 부작용을 유발하거나 건강한 육모를 형성하지 못하는 문제점들이 있었다.As much attention is currently focused on hair care, researches and inventions on cosmetic compositions prepared using natural extracts (medicinal herb extracts) with little irritation and fewer side effects to prevent the occurrence of hair loss are actively progressed. As a patent application for hair loss prevention, wool, hair growth promoting composition, hair loss prevention composition containing herbal extract containing thorny skin, pine needles, pine flower, gyoza, fresh sulfur and hair loss (Korea Patent Publication No. 10-2009-0051586), There are a number of patent applications such as hair loss prevention compositions (Korean Patent Application Publication No. 10-2005-0014473) using natural products, such as hair growth promoting compositions having a bactericidal function containing Baekduong, Daesan, and golden extracts. Thanks to such active research, various cosmetic compositions such as hair lotion, hair shampoo, hair treatment, hair rinse and the like for preventing hair loss are widely distributed and used in the market, but conventional cosmetic compositions commonly distributed are substantially There were no products with satisfactory effects on dandruff prevention and hair loss prevention, and there were problems that caused various side effects or failed to form healthy hair growth.
또한, 두피나 모발에 사용되는 조성물의 제품은 장기간 빈번하게 사용하므로 자극이나 손상 등의 부작용을 나타내지 않아야 하는데, 기존에 시판중인 제품들은 주성분이 화학물질인 경우가 많아 두피에 부작용을 유발하는 경우가 많다. 최근 미녹시딜, 프로페시아 같은 탈모치료제가 개발되어 탈모 치료 효과가 기대되고 있지만, 이러한 탈모 치료제를 적용할 경우, 체내 향상성의 불균형으로 인하여 성기능 감소나 알레르기, 우울증, 국소염증 등의 예기치 않은 부작용이 발생하여 그 적용 위험성이 점점 커지고 있는 실정이다.In addition, since the product of the composition used for the scalp or hair is frequently used for a long time, it should not show side effects such as irritation or damage, and existing commercially available products often cause side effects on the scalp because the main ingredient is a chemical. many. Recently, hair loss treatments such as minoxidil and propecia have been developed, and anti-hair loss effects are expected. However, the application of such hair loss treatments causes unexpected side effects such as decreased sexual function, allergies, depression, and local inflammation due to imbalances in improvement of the body. The risk of application is increasing.
본 발명자들은, 생약제 추출물을 함유한 탈모예방 및 모발생장 화장료 조성물에 관하여 연구하던 중, 황금 등의 천연물을 함유한 복합 조성물이 부작용이 없으면서도, 모근세포로의 혈액순환 뿐만 아니라 두피보호, 모발 영양공급 등의 체계적인 작용으로 탈모 예방 및 양모촉진 효과를 나타낸다는 점을 확인하고, 본 발명을 완성하였다.The inventors of the present invention, while studying hair loss prevention and hair growth cosmetic composition containing herbal extracts, complex composition containing natural products such as gold, without side effects, as well as blood circulation to the hair root cells, scalp protection, hair nutrition The present invention has been completed by confirming that a systematic effect such as feeding is to prevent hair loss and promote wool.
따라서, 본 발명의 목적은 황금 추출물, 하수오 추출물, 개자 추출물, 마치 현 추출물, 은행잎 추출물, 측백엽 추출물, 고삼 추출물 및 감초 추출물을 함유하는 탈모 예방 및 양모 촉진용 조성물을 제공하는데 있다.Accordingly, it is an object of the present invention to provide a composition for preventing hair loss and promoting wool containing golden extract, sewage extract, barberry extract, chome extract, ginkgo biloba extract, cypress leaf extract, red ginseng extract and licorice extract.
본 발명의 또 다른 목적은, 황금 추출물, 하수오 추출물, 개자 추출물, 마치현 추출물, 은행잎 추출물, 측백엽 추출물, 고삼 추출물 및 감초 추출물을 함유하는 탈모 예방 및 양모 촉진용 조성물의 제조방법을 제공하는데 있다.Still another object of the present invention is to provide a method for preparing hair loss prevention and wool promotion composition containing golden extract, sewage extract, bastard extract, guchi extract, ginkgo biloba extract, cedar leaf extract, red ginseng extract and licorice extract.
상기와 같은 목적을 달성하기 위해, 본 발명은 황금 추출물, 하수오 추출물, 개자 추출물, 마치현 추출물, 은행잎 추출물, 측백엽 추출물, 고삼 추출물 및 감초 추출물을 함유하는 탈모 예방 및 양모 촉진용 조성물을 제공한다.In order to achieve the above object, the present invention provides a composition for preventing hair loss and promoting wool containing golden extract, sewage extract, barberry extract, guchi extract, ginkgo biloba extract, cypress leaf extract, red ginseng extract and licorice extract.
본 발명은 또한, (a) 황금, 하수오, 개자, 마치현, 은행잎, 측백엽, 고삼 및 감초를 혼합하여 열수 추출하는 단계; 및 (b) 상기 열수 추출물을 가열하여 생성된 증기를 냉각시켜 증류액을 수득하여 탈모 예방 및 양모 촉진용 조성물을 제조하는 단계를 포함하는 탈모 예방 및 양모 촉진용 조성물의 제조방법을 제공한다.The present invention also comprises the steps of: (a) hot water extraction by mixing golden, sewage, barberry, machi, ginkgo biloba, cypress leaf, red ginseng and licorice; And (b) cooling the steam generated by heating the hot water extract to obtain a distillate to prepare a composition for preventing hair loss and promoting wool, and preparing a composition for preventing hair loss and promoting wool.
본 발명은 또한, (a) 황금, 하수오, 개자, 마치현, 은행잎, 측백엽, 고삼 및 감초 각각을 열수 추출하는 단계; 및 (b) 상기 각각의 열수 추출물을 가열하여 생성된 증기를 냉각시켜 각각의 증류액을 얻은 후 혼합하여 탈모 예방 및 양모 촉진용 조성물을 제조하는 단계를 포함하는 탈모 예방 및 양모 촉진용 조성물의 제조방법을 제공한다.The present invention also comprises the steps of: (a) hydrothermal extraction of each of the golden, sewage, barberry, machi, ginkgo biloba, cypress leaf, red ginseng and licorice; And (b) cooling the steam generated by heating the respective hydrothermal extracts to obtain respective distillates, and then mixing them to prepare a composition for preventing hair loss and promoting wool, including preparing a composition for preventing hair loss and promoting wool. Provide a method.
본 발명에 따른 탈모 예방 및 양모 촉진용 조성물은 천연물로 이루어져 인체 에 부작용이 없으며, 모근 세포로의 원활한 혈액 순환 뿐만 아니라, 두피보호 및 모발의 영양 공급 기능까지 있어 탈모 예방 및 양모 촉진에 탁월한 효과가 있다.Hair loss prevention and wool promotion composition according to the present invention is made of natural products have no side effects to the human body, as well as smooth blood circulation to the hair root cells, scalp protection and hair nourishment function has excellent effect in preventing hair loss and promoting wool have.
본 발명은 황금을 함유한 탈모 예방 및 양모 촉진용 조성물 및 그 제조방법에 관한 것으로, 유효성분으로써 황금 이외에도 하수오 추출물, 개자 추출물, 마치현 추출물, 은행잎 추출물, 측백엽 추출물, 고삼 추출물, 감초 추출물 등을 포함한 천연성분을 함유한 탈모 예방 및 양모 촉진용 조성물에 관한 것이다.The present invention relates to a composition for preventing hair loss and promoting wool containing golden and a method for producing the same, including sewage extract, barberry extract, machiko extract, ginkgo biloba extract, cypress leaf extract, red ginseng extract, licorice extract and the like as an active ingredient. It relates to a composition for preventing hair loss and promoting wool containing natural ingredients.
본 발명은 일 관점에서, 황금 추출물, 하수오 추출물, 개자 추출물, 마치현 추출물, 은행잎 추출물, 측백엽 추출물, 고삼 추출물 및 감초 추출물을 함유하는 탈모 예방 및 양모 촉진용 조성물에 관한 것이다.The present invention relates to a composition for preventing hair loss and promoting wool containing golden extract, sewage extract, bastard extract, guchi extract, ginkgo biloba extract, cypress leaf extract, red ginseng extract and licorice extract.
구체적으로, 본 발명은, 상기 조성물은 황금 추출물 10~30중량부, 하수오 추출물 1~25중량부, 개자 추출물 1~20중량부, 마치현 추출물 1~20중량부, 은행잎 추출물 0.01~20중량부, 측백엽 추출물 1~25중량부, 고삼 추출물 1~25중량부 및 감초 추출물 1~20중량부를 함유하는 것을 특징으로 할 수 있다.Specifically, the present invention, the composition is 10-30 parts by weight of golden extract, 1-25 parts by weight of sewage extract, 1-20 parts by weight of barberry extract, 1-20 parts by weight of Machiko extract, 0.01-20 parts by weight of ginkgo leaf extract, It may be characterized by containing 1 to 25 parts by weight of the baekbaek leaf extract, 1 to 25 parts by weight of ginseng extract and 1 to 20 parts by weight of licorice extract.
바람직하게는, 상기 황금 추출물의 함량이 18~22 중량부이고, 상기 하수오 추출물의 함량이 13~17 중량부이고, 상기 개자 추출물의 함량이 8~12 중량부이고, 상기 마치현 추출물의 함량이 8~12 중량부이고, 상기 은행잎 추출물의 함량이 3~7 중량부이고, 상기 측백엽 추출물의 함량이 13~17 중량부이고, 상기 고삼 추출물의 함량이 13~17 중량부이고, 상기 감초 추출물의 함량이 8~12 중량부이다.Preferably, the content of the golden extract is 18 to 22 parts by weight, the content of the sewage extract is 13 to 17 parts by weight, the content of the individual extract is 8 to 12 parts by weight, the content of the extract of Machi Prefecture is 8 ~ 12 parts by weight, the content of the ginkgo biloba extract is 3-7 parts by weight, the content of the cypress leaf extract is 13-17 parts by weight, the content of the red ginseng extract is 13-17 parts by weight, the content of the licorice extract It is 8-12 weight part.
만약, 각각의 추출물의 함량이 상기 정해진 함량 범위 미만이면 탈모 예방 및 양모 촉진 효과가 미미하고, 또한, 정해진 범위의 중량부를 초과하면 제형 및 안정성에 영향을 미치게 되어 바람직하지 못하다.If the content of each extract is less than the content range, the effect of preventing hair loss and promoting wool is insignificant, and if the content exceeds the weight range, the formulation and stability may be adversely affected.
여기서, 조성물 전체 100중량부에 대하여, 황금 추출물은 10 내지 30중량부를 함유하는 것이 바람직하다. 황금 추출물의 함량이 10중량부 미만이면 탈모 예방 및 양모 촉진효과가 미미하고, 30중량부를 초과하면 조성물의 제조단가가 상승하여 바람직하지 못하다.Here, it is preferable that a golden extract contains 10-30 weight part with respect to 100 weight part of compositions. If the content of the golden extract is less than 10 parts by weight, hair loss prevention and wool promoting effect is insignificant, and if it exceeds 30 parts by weight, the production cost of the composition is not preferable to increase.
상기 하수오, 개자, 마치현, 은행잎, 측백엽, 고삼 및 감초 추출물의 함량은 각각 1 내지 30중량부이며, 1중량부 미만이면, 탈모 개선 효과가 미미하고, 30중량부를 초과하면 조성물의 제조단가가 상승하여 바람직하지 못하다.The content of the sewage, individual fruit, machi, ginkgo biloba, ginseng leaf, red ginseng and licorice extract is 1 to 30 parts by weight, respectively, if less than 1 part by weight, the hair loss improvement effect is insignificant, and if the content exceeds 30 parts by weight It is not preferable.
본 발명에 있어서, 상기 황금 추출물, 하수오 추출물, 개자 추출물, 마치현 추출물, 은행잎 추출물, 측백엽 추출물, 고삼 추출물 및 감초 추출물들은 열수추출하거나, 에탄올 추출하여 얻을 수 있고, 예컨대, 물, 탄소수 1-4의 무수 또는 함수 저급 알코올, 상기 저급 알코올과 물과의 혼합용매, 아세톤, 에틸 아세테이트, 클로로포름 또는 1,3-부틸렌글리콜 등을 이용하여, 또는 기타 기술분야에 알려져 있는 다른 추출방법에 의해서도 얻을 수 있다.In the present invention, the golden extract, sewage extract, bastard extract, guchi extract, ginkgo biloba extract, cypress leaf extract, red ginseng extract and licorice extract can be obtained by hot water extraction or ethanol extract, for example, water, 1-4 Anhydrous or hydrous lower alcohols, mixed solvents of the lower alcohols with water, acetone, ethyl acetate, chloroform or 1,3-butylene glycol and the like, or by other extraction methods known in the art. .
이하 본 발명의 조성물이 함유하는 각 천연물 성분에 대해 상세히 설명한다.Hereinafter, each natural product component contained in the composition of the present invention will be described in detail.
황금(Scultellaria baicallensis)은 꿀풀과(Labiatae)에 속한 다년생 본초인 황금의 뿌리를 거피하여 건조한 것으로 제습열, 지혈, 안태(安胎)의 효능이 있어 임상에서 황련해독탕(黃連解毒湯), 용담사간탕(龍膽瀉肝湯), 우황청심환(牛黃淸心丸) 등 처방으로 고혈압, 유행성 뇌척수막염(腦脊髓膜炎)의 치료에 사용되어 온 한 약재이다(김 동찬, 노승현, 이상인, 이영종, 주영승 : 方劑學, 서울, 永林社, 1990, pp.111-113, pp263-264, p338). 이에 대한 성분으로는 우고닌(wogonin), 바이칼린(baicalin), 바이칼레인(baicalein) 등 여러 종류의 플라보노이드들이 함유된 것으로, 약리 효과로는 심장 및 폐의 열을 내리게 하거나 기침 및 피를 멈추게 하는 효과를 갖고 있다. 피부에는 항알레르기, 항산화, 항염증 효과를 갖고 있고 유해 산소 제거 효과가 우수하다.Golden ( Scultellaria baicallensis ) is dried from the root of golden, a perennial herb belonging to the Lamiaceae family, and has the effect of dehumidification fever , hemostasis, and anemia. This medicine is used for the treatment of hypertension and epidemic meningitis (Kim Dong-chan, Roh Seung-hyun, Lee Sang-in, Lee Young-jong, Ju Young-seung). : Yeonglin Co., Seoul, 1990, pp.111-113, pp263-264, p338). It contains several types of flavonoids, such as wogonin, baicalin, and baicalein.The pharmacological effect is to reduce the heat of the heart and lungs or to stop coughing and blood. It has an effect. The skin has anti-allergic, antioxidant, and anti-inflammatory effects, and is excellent in removing harmful oxygen.
하수오(Cynanchum silfordii Hemsley)는 여뀌과에 속하는 다년생 덩굴초본으로 산삼과 견줄만한 약성을 인정받으며, 성질은 따뜻하고 맛은 쓰고 떫으며 독이 없다. 하수오는 고구마처럼 생겼는데 그보다 약간 작고, 인삼이 귀할 때는 인삼 대신으로, 숙지황이 없으면 대용품으로, 또는 숙지황이 있어도 숙지황보다 금기 기운이 덜하고 소화가 잘되기 때문 하수오를 쓰기도 하였다. 하수오는 당귀나 숙지황의 기능과 같이 피를 생성하여 원활하게 해주는 작용, 염증, 종기, 부스럼을 없애주는 작용을 하고 이외에도 가래와 담을 삭히고 부인의 산후병, 냉, 대하 등을 치료하고, 골수를 채우며, 근골을 튼튼하게 하는 작용이 있다. 생으로 쓸 경우에는 기운을 소통시켜 대변 소통을 원활히 해주는 작용 외에 해독작용을 하기도 하며 적당히 찌거나 삶은 다음에 말려서 쓰면 간과 신을 보해서 혈과 정이 생겨나게 한다. 머리를 검게 할 목적으로는 사용할 때는 검은 콩, 검은 깨와 함께 사용하는 것이 좋다고 되어 있다. 특히, 자외선을 효과적으로 흡수하여 두피와 모발의 노화방지제로서 효과적이며 항산화 작용과 수렴 작용 등을 통한 피부와 두피 노화 예방에 효과를 보인다. 안트라퀴논(Anthraquinone) 유도체가 함유되어 있는데, 주성분은 크리소파 닉산(chrysophanic acid), 크리소파놀(chrysophanol), 에모딘(emodin), 안트로넨(anthronene), 레인(rhein), 전분이며 옴과 습진 등의 피부병에 쓰이고 알러지로 인한 피부소양증을 억제하고 항산화작용과 수렴작용 등을 통한 노화예방효과를 보이며 흰머리를 검게 해주고 자외선 UV-B영역을 효과적으로 흡수하여 두피와 모발의 노화방지에 효과적이다. Synao ( Cynanchum silfordii Hemsley ) is a perennial vine herb that belongs to Yeowi-gu and is recognized for its weakness compared to wild ginseng. Sewage looks like sweet potato, but slightly smaller, and when ginseng is precious, instead of ginseng, it is used as a substitute for sukji, or because there is less contraindication and better digestion than sukji. Sewage acts as a function of donkey and succinct amber to produce blood and removes inflammation, boils and swelling. In addition to sputum and phlegm, it treats postpartum disease, cold and lobular treatment of women, and fills bone marrow. There is a function to strengthen the musculature. When used as a life to communicate the energy to facilitate the communication of faeces and detoxification action, and steaming properly or boiled and then dried to write the liver and gods to create blood courses. For the purpose of blackening hair, black beans and black sesame seeds are recommended for use. In particular, it effectively absorbs ultraviolet rays and is effective as an anti-aging agent for scalp and hair, and is effective in preventing skin and scalp aging through antioxidant and astringent effects. It contains anthraquinone derivatives, the main constituents of which are chrysophanic acid, chrysophanol, emodin, anthronene, rhein, starch, It is used in skin diseases such as eczema, suppresses skin pruritus caused by allergy, shows anti-aging effect through antioxidant and astringent effect, blackens gray hair and effectively absorbs UV-B area of scalp and prevents aging of scalp and hair.
개자(Sinapis Semen)는 십자화과(十字花科)에 속하는 초본인 개자(Brassica juncea)의 성숙한 씨를 말린 것이다. 주요 생리활성 성분으로 황화합물로는 sinigrin, 8-(methylsulfonyl)octyl glucosinolate이고 phytoalexin으로는 brassinin, cyclobrassinin이 있다.피부에 바르면 피부 및 점막을 자극하여 그 국부와 관계가 있는 내장,관절, 근육의 혈류를 증가시키는 피부인적작용, 국소자극약 및 발포약등으로 사용되며, 식욕향진과 방부의 효과가 있다. Sinapis Semen is a dried seed of Brassica juncea, a herbaceous genus belonging to the Cruciferaceae. The major physiologically active compounds are sulfur compounds such as sinigrin, 8- (methylsulfonyl) octyl glucosinolate, and phytoalexin include brassinin and cyclobrassinin. It is used for increasing skin human action, topical stimulant and foaming medicine. It has appetite and antiseptic effect.
마치현(馬齒, Portulaca oleracea)은 주성분으로는 ℓ-노르아드레날린(noradrenaline), 도파민(dopamine), 알칼로이드(alkaloid), 칼륨염, 유기산(사과산, 레몬산, 상아산), 아미노산(글루탐산, 아스파라긴산, 알라닌) 등이며, 마른 물질은 조단백 4.5 ~ 6.6%, 조지방 3.7 ~ 5.8%, 조회분 25 ~ 27%, 단당류 2 ~ 3%, 사탕 4.4 ~ 6%, 물 분해되기 쉬운 다당류 9 ~ 14%, 녹말 0.2 ~ 2.5%, 비타민 B1과 C, 카로틴 9.4 ~ 17mg%, 니코틴산 25 ~ 50mg%, 토코페롤 2 ~ 6mg%, 미량원소인 아연, 동, 망간, 니켈, 철 등으로 이루어져 있으며, 피부자극 및 알러지 반응 진정작용, 피부 건조 예방 및 항염작용으로 노화예방, 항균 및 항진균의 효과를 보인다. Portulaca oleracea consists of l-noradrenaline, dopamine, alkaloid, potassium salt, organic acid (apple acid, lemon acid, ivory acid), amino acids (glutamic acid, aspartic acid, alanine). The dry matter is crude protein 4.5-6.6%, crude fat 3.7-5.8%, crude ash 25-27%, monosaccharides 2-3%, candy 4.4-6%, water-degradable polysaccharides 9-14%, starch 0.2 ~ 2.5%, vitamins B1 and C, carotene 9.4 ~ 17mg%, nicotinic acid 25 ~ 50mg%, tocopherol 2 ~ 6mg%, trace elements zinc, copper, manganese, nickel, iron, etc., soothing skin irritation and allergic reaction It has the effect of preventing aging, antibacterial and antifungal by action, prevention of skin dryness and anti-inflammatory action.
은행잎 추출물은 은행나무과에 속하는 낙엽성 교목인 은행(Ginko biloba L.)으로부터 추출되며 은행잎에는 인체의 프리라디칼(유해산소) 제거, 항산화작용, 세포막 보호, 혈관질환개선, 혈압 강하작용 등을 가진 플라보노이드를 비롯하여 혈액순환 개선, 혈전 제거, 혈액 노화 예방, 피부노화 억제, 건성피부 보호 및 얼굴의 잔주름을 막아주는 각종 물질이 함유되어 있다. 또한, 항균작용과 더불어 항알레르기 효과 등을 지니고 있다. 일반적으로 은행잎 추출물은 잎의 플라보노이드와 방향족 옥시카르복시산으로 이루어진 종합성분으로써 프라본그리코사이드류, 징코닉애씨드,징코게틴, 징코화이드 A,B,C,M, 텔펜락톤류 등의 유효성분을 포함하고 있다.Ginkgo biloba extract is extracted from Ginkgo biloba L., a deciduous tree belonging to the Ginkgo family, and Ginkgo biloba leaves contain flavonoids with free radicals, antioxidants, cell membrane protection, vascular diseases, and blood pressure lowering. In addition, it contains various substances that improve blood circulation, remove blood clots, prevent blood aging, inhibit skin aging, protect dry skin and prevent fine wrinkles on the face. In addition, it has an antiallergic effect as well as antibacterial action. In general, ginkgo biloba extract is composed of flavonoids and aromatic oxycarboxylic acids of the leaves and contains active ingredients such as prabon glycosides, ginkonic acids, ginkgo gettins, ginkgoides A, B, C, M, and tefenlactones. It is included.
상기 은행잎 추출물에 함유되어 있는 생물활성을 나타내는 주성분은 플라보노이드계 화합물(flavonoids), 테르펜계 화합물(terpenes)과 탄닌인 프로안토시아니딘류(proanthocyanidins)이며, 그 밖에 알킬페놀류(alkylphenols)가 있다. 은행잎의 플라보노이드 성분은 화학적으로 플라보놀 글리코시드류(flavonol glycosides)와 바이플라본류(biflavones)로 분류할 수 있으며 바이플라본류에는 시아도피티신(sciadopitysin), 징크게틴(ginkgetin), 이소징게틴(isoginkgetin), 바일로베틴(bilobetin), 아멘토플라본(amentoflavone) 등이 보고 되었으며, 플라보놀 글리코시드류에는 비당체(aglycone)의 종류에 따라 캠페롤(kaempferol), 퀘르세틴(quercetin)및 이소람네틴(isorhamnetin)의 배당체로 대별될 수 있다. 테르펜류 화합물은 징골리드(ginkgolide) A, B, C 및 J와 바일로발리드(bilobalide)로 알려져 있다. 이러한 성분들 중에서 특히 이소람네틴(isorhamnetin)과 퀘르세틴(quercetin)은 관상 혈관을 확장시켜 두피의 혈액순환을 촉진하며, 징크게틴 (ginkgetin)은 혈중 콜레스테롤의 함량을 저하시켜 상당한 혈압강하 작용을 한다. 이들은 또한 녹농균, 황색포도상구균, 피부진균에 대하여 항균 작용이 있어 은행잎의 추출물을 모발용 조성물에 첨가하여 사용시 비듬을 방지하고 두피의 가려움증을 제거할 수 있다.The main components exhibiting biological activity contained in the ginkgo biloba extract are flavonoid compounds, terpenes, and tannins, proanthocyanidins, and alkylphenols. Flavonoids of ginkgo biloba can be chemically classified into flavonol glycosides and biflavones. Biflavones include sciadopitysin, ginkgetin, and isotizing (isoginkgetin), bilobetin, and amentoflavone have been reported, and flavonol glycosides include kaempferol, quercetin and isoram, depending on the type of aglycone. It can be roughly classified as a glycoside of isorhamnetin. Terpene compounds are known as ginkgolides A, B, C and J and bilobalides. Among these components, especially isorhamnetin and quercetin dilate coronary vessels to promote blood circulation in the scalp, and ginkgetin lowers blood cholesterol and significantly lowers blood pressure. . They also have antimicrobial activity against Pseudomonas aeruginosa, Staphylococcus aureus, and skin fungi, so that the extract of ginkgo biloba can be added to the hair composition to prevent dandruff and to remove the itching of the scalp.
측백엽(側柏葉, Cacumen biotae)은 주성분으로는 쿠에르세틴(quercetin), 미리세틴(myricetin), 펜콘(fenchone), 알파-피넨(α-pinene), 알파-카리오필렌(α-caryophyllene), 튜젠(thujone), 히노키플라본(hinokiflavone) 등이 함유되어 있고, 항균작용, 살균 작용, 지혈작용, 모발생장, 모포부활, 모발의 백화와 탈모에 효과적이다.Cacumen biotae consists of quercetin, myricetin, fenchone, alpha-pinene, alpha-caryophyllene, and tujen It contains thujone and hinokiflavone, and is effective for antibacterial, bactericidal, hemostatic, hair growth, follicular regeneration, and hair whitening and hair loss.
고삼(Sophorae Radix)은 다년생 초본으로 뿌리를 말하며 봄과 가을에 채취한다. 뿌리에는 알카로이드(Alkaloid)류인 d-마트린(matrine), d-옥시마트린(oxymatrine), d-소포라놀(sophoranol), l-메틸 시티신(methylcytisine), l-밥티폴린(baptifoline) 및 l-소포카르핀(sophocarpine)이 함유되어 있고, 플라보노이드(Flavonoid)류의 잔토휴몰, 이소잔토휴몰 및 캠프페롤 등이 함유되어 있다. 주요 효능으로는 이뇨 작용 및 항균 효과 등이 있다.Ginseng ( Sophorae Radix ) is a perennial herb and refers to its roots and is harvested in spring and autumn. Roots include alkaloids d-matrine, d-oxymatrine, d-sophoranol, l-methylcytisine, l-baptifoline and l -Sopocarpine is contained, and flavonoids such as xanthohumol, isoxanthohumol and camphorol are contained. Main effects include diuretic and antibacterial effects.
감초(Glycyrrhiza glabra)는 콩과 다년생 초본식물로 항염증, 항알레르기, 항균효과가 우수하고 피부탄력, 주름개선, 피부보습 효과와 밀접한 관련이 있는 콜라겐 합성 및 히아론산 합성 증진효과가 우수하다. 감초의 생리활성의 주성분으로는 글리시리친(Glycyrrhizin), 후라보노이드(Flavonoid), 마니톨(mannitol) 등이다.Licorice ( Glycyrrhiza glabra ) is a soybean and perennial herbaceous plant that has excellent anti-inflammatory, anti-allergic and antibacterial effects, and has an excellent effect on collagen synthesis and hyaluronic acid synthesis, which are closely related to skin elasticity, wrinkle improvement and skin moisturizing effect. The main components of the physiological activity of licorice are glycyrrhizin, flavonoids and mannitol.
본 발명의 탈모 예방 및 양모 촉진용 조성물은 일반적인 두피 및 모발용 외용제제에 배합될 수 있는 기제 성분을 필요에 따라 추가할 수 있다. 구체적으로는 용해보조제, 계면활성제, 보습제, 점증제, pH 조정제,방부제, 산화방지제, 금속이온봉쇄제, 살균제, 항염증제, 항미생물제, 용제, 착색제, 또는 착향제 등이 있다.The composition for preventing hair loss and promoting hair of the present invention may add a base component that can be blended into general scalp and hair external preparations as needed. Specific examples include dissolution aids, surfactants, moisturizers, thickeners, pH adjusters, preservatives, antioxidants, metal ion sequestrants, fungicides, anti-inflammatory agents, antimicrobial agents, solvents, colorants, or flavoring agents.
여기서, 용해보조제는 구체적으로 이소프로필 미리스테이트, 폴리에틸렌 글리콜, 중쇄 지방산 트리글리세리드, 탄화수소, 글리콜류 등이 될 수 있다.Here, the dissolution aid may be specifically isopropyl myristate, polyethylene glycol, medium chain fatty acid triglycerides, hydrocarbons, glycols and the like.
계면활성제 중 음이온계 계면활성제는 구체적으로 암모늄 라우릴술포숙시네이트, 암모늄 라우릴 설페이트, 소디움 코코일이세시오네이트, 소디움 라우릴 이세시오네이트, 소디움 라우릴 설페이트, 트리에탄올아민 라우릴 설페이트, 소디움 라우릴 에테르 설페이트(에틸렌옥사이드 1~3개) 등이 될 수 있다. 계면활성제 중 비이온성 계면활성제는 구체적으로 폴리옥시에틸렌알킬에테르, 폴리옥시에틸렌지방산에스테르, 폴리옥시에틸렌, 경화 피마자유 유도체, 지방산 디에탄올아미드, 글리세릴스테아레이트 등이 될 수 있다. 계면활성제 중 양이온성 계면활성제는 구체적으로 3급 지방족 아민염, 알킬트리메칠암모늄클로라이드, 디알킬디메칠암모늄클로라이드 등이 될 수 있다. 계면활성제 중 양쪽성 계면활성제는 구체적으로 베타인, 아미드베타인형, 설포베타인형, 스테아르트리모늄클로라이드 등이 될 수 있다.Among the surfactants, anionic surfactants are specifically ammonium lauryl sulfosuccinate, ammonium lauryl sulfate, sodium cocoyl isionate, sodium lauryl isceionate, sodium lauryl sulfate, triethanolamine lauryl sulfate, sodium Lauryl ether sulfate (1 to 3 ethylene oxide) and the like. Among the surfactants, nonionic surfactants may specifically be polyoxyethylene alkyl ethers, polyoxyethylene fatty acid esters, polyoxyethylene, hardened castor oil derivatives, fatty acid diethanolamides, glyceryl stearate, and the like. The cationic surfactant in the surfactant may specifically be a tertiary aliphatic amine salt, alkyltrimethylammonium chloride, dialkyldimethylammonium chloride, or the like. Among the surfactants, the amphoteric surfactant may be specifically betaine, amidebetaine type, sulfobetaine type, steartrimonium chloride, or the like.
보습제는 구체적으로 글리세린, 프로필렌글리콜, 1,3-부틸렌글리콜, 디프로필렌글리콜, 소르비톨 등이 될 수 있다.Moisturizing agent may be specifically glycerin, propylene glycol, 1,3-butylene glycol, dipropylene glycol, sorbitol and the like.
점증제는 구체적으로 메틸셀룰로스, 하이드록시에틸셀룰로스, 카라기난, 카르복시메틸셀룰로스, 하이드록시메틸셀룰로스 등의 수용성 고분자 화합물이 될 수 있다.The thickener may specifically be a water-soluble high molecular compound such as methyl cellulose, hydroxyethyl cellulose, carrageenan, carboxymethyl cellulose, hydroxymethyl cellulose and the like.
pH 조정제는 구체적으로 구연산, 수산화나트륨, 트리에탄올아민, 구연산나트륨, 인산, 인산나트륨, 젖산 등이 될 수 있다.The pH adjusting agent may specifically be citric acid, sodium hydroxide, triethanolamine, sodium citrate, phosphoric acid, sodium phosphate, lactic acid and the like.
방부제는 구체적으로 벤조산, 파라옥시안식향산에스테르, 메칠클로로이소치아졸리논의 혼합물, 페녹시에탄올, 디엠디엠히단토인 등이 될 수 있다.Preservatives may specifically be benzoic acid, paraoxybenzoic acid esters, mixtures of methylchloroisothiazolinone, phenoxyethanol, DMDM hydantoin and the like.
산화방지제는 구체적으로 디부틸히드록시톨루엔, 아스코르빈산 등이 될 수 있다.Antioxidants may specifically be dibutylhydroxytoluene, ascorbic acid and the like.
금속이온봉쇄제는 구체적으로 에틸렌디아민테트라초산디나트륨, 에틸렌디아민테트라초산테트라나트륨 등이 될 수 있다.Specifically, the metal ion blocking agent may be ethylenediaminetetraacetate acetate, ethylenediaminetetraacetate tetrasodium, or the like.
살균제는 구체적으로 클로르헥시딘 글루코네이트, 4급 암모늄염, 피록톤올아민, 아연피리치온 현탁액, 요도프로피닐 부틸카바메이트, 살리실산 등이 될 수 있다.Fungicides may specifically be chlorhexidine gluconate, quaternary ammonium salts, pyroxtonolamines, zinc pyrithione suspensions, iodopropynyl butylcarbamate, salicylic acid and the like.
항염증성분은 구체적으로 글리시리진산모노암모늄, 글리시리진산디칼륨, 스테아릴글리시리지네이트, 카모마일, 알파 비사보롤, 알란토인 및 이들의 혼합물 등이 될 수 있다.The anti-inflammatory component may specifically be monoammonium glycyrrhinate, dipotassium glycyrizine, stearyl glycyrizinate, chamomile, alpha bisabolol, allantoin and mixtures thereof.
항미생물성분은 구체적으로 페녹시에탄올, 클로르헥시딘, 클로르헥시딘 글루코네이트, 피록톤올아민, 케토코나졸, 아르니카추출물, 요도프로피닐부틸카바메이트, 벤잘코늄클로라이드, 벤젠토늄클로라이드, 벤조산 및 그의염, 벤질알코올, 라벤다, 로즈마리, 살리실산, 트리클로카르반, 아연피리치온 현탁액 및 그들의 혼합물 등이 될 수 있다.The antimicrobial component is specifically phenoxyethanol, chlorhexidine, chlorhexidine gluconate, pyroxtonolamine, ketoconazole, arnica extract, iodopropynylbutylcarbamate, benzalkonium chloride, benzenetonium chloride, benzoic acid and salts thereof, benzyl alcohol, lavender, Rosemary, salicylic acid, triclocarban, zinc pyrithione suspensions and mixtures thereof and the like.
용제는 구체적으로 에탄올, 정제수, 트윈 20, 사이클로메치콘, 미네랄오일, 디메치콘 등이 될 수 있다.The solvent may be specifically ethanol, purified water, Tween 20, cyclomethicone, mineral oil, dimethicone, and the like.
착색제와 착향제는 일반적인 두피 및 모발용 제제에 사용되는 기제들을 사용할 수 있다.Colorants and flavoring agents can use the bases used in general scalp and hair preparations.
본 발명의 탈모 예방 및 양모 촉진용 조성물은 액상, 크림상, 페이스트상 또는 고체상 등의 통상적으로 두피 및 모발에 적용시킬 수 있는 모든 제형으로 제조될 수 있으며, 통상의 첨가제를 가하여 모발성장촉진을 위한 샴푸, 헤어컨디셔너, 헤어로션, 헤어토닉, 헤어팩, 삼푸와 린스의 혼합형, 액상의 양모제 타입 등의 조성물로 제조될 수 있으며 이들 제형의 에어졸 타입도 포함한다. 상기 탈모 예방 및 양모 촉진용 조성물은 두피나 모발에 직접 도포하거나 살포하는 등의 경피 투여 방법으로 사용하는 것이 바람직하다.Hair loss prevention and promotion of the composition of the present invention can be prepared in any formulation that can be applied to the scalp and hair in a liquid, cream, paste or solid form, etc., and to promote hair growth by adding a conventional additives Shampoos, hair conditioners, hair lotions, hair tonics, hair packs, blends of shampoos and rinses, liquid wool types, and the like, and also include aerosol types of these formulations. The composition for preventing hair loss and promoting wool is preferably used in a method of transdermal administration such as direct application or spraying to the scalp or hair.
본 발명은 다른 관점에서, (a) 황금, 하수오, 개자, 마치현, 은행잎, 측백엽, 고삼 및 감초를 혼합하여 열수 추출하는 단계; 및 (b) 상기 열수 추출물을 가열하여 생성된 증기를 냉각시켜 증류액을 수득하여 탈모 예방 및 양모 촉진용 조성물을 제조하는 단계를 포함하는 탈모 예방 및 양모 촉진용 조성물의 제조방법에 관한 것이다.In another aspect, the present invention comprises the steps of: (a) hot water extraction by mixing golden, sewage, barberry, machi, ginkgo biloba, cypress leaf, red ginseng and licorice; And (b) cooling the steam produced by heating the hot water extract to obtain a distillate to prepare a composition for preventing hair loss and promoting hair growth, including preparing a composition for promoting hair loss.
본 발명은 또 다른 관점에서, (a) 황금, 하수오, 개자, 마치현, 은행잎, 측백엽, 고삼 및 감초 각각을 열수 추출하는 단계; 및 (b) 상기 각각의 열수 추출물을 가열하여 생성된 증기를 냉각시켜 각각의 증류액을 얻은 후 혼합하여 탈모 예방 및 양모 촉진용 조성물을 제조하는 단계를 포함하는 탈모 예방 및 양모 촉진용 조 성물의 제조방법에 관한 것이다.In another aspect, the present invention, (a) hydrothermal extraction of each of the golden, sewage, barberry, machi, ginkgo biloba, cypress leaf, red ginseng and licorice; And (b) cooling the steam generated by heating the respective hydrothermal extracts to obtain respective distillates, and then mixing them to prepare a composition for preventing hair loss and promoting wool, comprising the steps of: It relates to a manufacturing method.
상기 제조방법에 있어서, 황금, 하수오, 개자, 마치현, 은행잎, 측백엽, 고삼 및 감초를 혼합하여, 열수추출하거나 또는, 상기 황금, 하수오, 개자, 마치현, 은행잎, 측백엽, 고삼 및 감초 각각을 열수추출할 수 있다.In the manufacturing method, hot water extraction by mixing golden, sewage, barberry, machi, ginkgo biloba, cypress leaves, red ginseng and licorice, or hot water extraction of each of the golden, sessau, barberry, machi, ginkgo biloba, cypress leaves, ginseng and licorice can do.
상기 천연물의 각각의 중량비는 황금 추출물 10~30중량부, 하수오 추출물 1~25중량부, 개자 추출물 1~20중량부, 마치현 추출물 1~20중량부, 은행잎 추출물 0.01~20중량부, 측백엽 추출물 1~25중량부, 고삼 추출물 1~25중량부 및 감초 추출물 1~20중량부, 바람직하게는, 황금 추출물 18~22 중량부, 하수오 추출물 13~17 중량부, 개자 추출물 8~12 중량부, 마치현 추출물 8~12 중량부, 은행잎 추출물 3~7 중량부, 백엽 추출물 13~17 중량부, 고삼 추출물 13~17 중량부, 감초 추출물 8~12 중량부일 수 있다.The weight ratio of each natural product is 10-30 parts by weight of golden extract, 1-25 parts by weight of sewage extract, 1-20 parts by weight of barberry extract, 1-20 parts by weight of Machi Prefecture extract, 0.01-20 parts by weight of ginkgo biloba extract, white leaf extract 1 ˜25 parts by weight, 1 to 25 parts by weight of red ginseng extract and 1 to 20 parts by weight of licorice extract, preferably 18 to 22 parts by weight of golden extract, 13 to 17 parts by weight of sewage extract, 8 to 12 parts by weight of barley extract, Machi 8 to 12 parts by weight of extract, 3 to 7 parts by weight of ginkgo leaf extract, 13 to 17 parts by weight of white leaf extract, 13 to 17 parts by weight of red ginseng extract, 8 to 12 parts by weight of licorice extract.
또한, 상기 열수추출 후에는, 사용된 재료들은 제거하고, 열수추출물을 80~100℃로 가열한 다음, 증기를 4~10℃의 냉수 냉각관을 이용하여 증류액을 수득한다. 여기서, 추가적으로, 상기 증류액을 원심분리하여, 고형분을 제거한 다음, 조성물을 얻을 수도 있다. 여기서, 추가적으로, 상기 증류액을 12000rpm으로 원심분리하여, 고형분을 제거한 다음, 조성물을 얻을 수도 있다. 상기 열수추출방법, 증류액의 원심분리, 고형분 제거 과정은 본 발명이 속한 통상의 기술분야에서 널리 행해지는 다양한 방법이 적용가능할 것이다.In addition, after the hot water extraction, the materials used are removed, the hot water extract is heated to 80 ~ 100 ℃, the steam is obtained by using a cold water cooling tube of 4 ~ 10 ℃. Here, the distillate may be further centrifuged to remove solids, and then the composition may be obtained. In addition, the distillate may be centrifuged at 12000 rpm to remove solids, and then the composition may be obtained. The hot water extraction method, centrifugation of the distillate, solids removal process will be applicable to a variety of methods widely used in the art.
상기 본 발명에 따른 탈모 방지 및 양모 촉진용 조성물은 통상적으로 두피 및 모발에 적용할 수 있는 화장품 조성물의 형태로 제조될 수 있다. 일 예로 삼푸, 헤어트리트먼트, 헤어토닉, 헤어팩, 삼푸와 린스의 혼합형 등으로 제조될 수 있다.The composition for preventing hair loss and promoting wool according to the present invention may be prepared in the form of a cosmetic composition that can be commonly applied to the scalp and hair. For example, it may be prepared by shampoo, hair treatment, hair tonic, hair pack, mixed type of shampoo and rinse.
또한, 본 발명의 탈모 방지 및 양모 촉진용 조성물은 약제학적 조성물의 형태일 수 있다. 상기 약제학적 조성물의 경우는, 약제학적으로 적합하며 생리학적으로 허용되는 보조제를 추가로 함유하여 제조될 수 있으며, 상기 보조제로는 용매, 붕해제, 감미제, 결합제, 피복제, 팽창제, 윤활제, 활택제 또는 향미제 등의 가용화제를 사용할 수 있다. 또한, 적절한 투여를 위해 상기 기재한 유효성분 이외에, 약제학적으로 허용 가능한 담체를 1종 이상 추가로 포함하여 제제화할 수 있다. 여기서, 약제학적으로 허용 가능한 담체는 식염수, 멸균수, 링거액, 완충 식염수, 덱스트로즈 용액, 말토 덱스트린 용액, 글리세롤, 에탄올 및 이들 성분 중 하나 이상을 혼합하여 사용할 수 있으며, 필요에 따라 항산화제, 완충액, 정균제 등 다른 통상의 첨가제를 첨가할 수 있다.In addition, the composition for preventing hair loss and promoting wool of the present invention may be in the form of a pharmaceutical composition. In the case of the pharmaceutical composition, it may be prepared by further containing a pharmaceutically suitable and physiologically acceptable adjuvant, wherein the adjuvant includes a solvent, a disintegrant, a sweetener, a binder, a coating agent, an expanding agent, a lubricant, a lubricant Solubilizers, such as an agent or a flavoring agent, can be used. In addition, in addition to the active ingredient described above for proper administration, it may be formulated to include one or more additional pharmaceutically acceptable carriers. Here, the pharmaceutically acceptable carrier may be used in combination with saline solution, sterile water, Ringer's solution, buffered saline solution, dextrose solution, maltodextrin solution, glycerol, ethanol and one or more of these components, if necessary, antioxidants, Other conventional additives such as buffers and bacteriostatic agents can be added.
또한 상기 탈모 방지 및 양모 촉진용 약제학적 조성물은 희석제, 분산제, 계면활성제, 결합제 및 윤활제를 부가적으로 첨가하여 수용액, 현탁액, 유탁액 등과 같은 주사용 제형, 환약, 캡슐, 과립 또는 정제로 제제화할 수 있다. 목적하는 방법에 따라 정맥내, 동맥내, 복강내, 근육내, 동맥내, 복강내, 흉골내, 경피, 비측내, 흡입, 국소, 직장, 경구, 안구내 또는 피내 경로를 통해 통상적인 방식으로 투여할 수 있다.In addition, the pharmaceutical composition for preventing hair loss and promoting wool may be formulated into injectable formulations such as aqueous solutions, suspensions, emulsions, pills, capsules, granules or tablets by additionally adding diluents, dispersants, surfactants, binders and lubricants. Can be. In the usual manner via the intravenous, intraarterial, intraperitoneal, intramuscular, intraarterial, intraperitoneal, sternum, transdermal, nasal, inhalation, topical, rectal, oral, intraocular or intradermal routes May be administered.
상기 약제학적 조성물 또는 화장료 조성물은, 본 발명의 황금, 하수오, 개자, 마치현, 은행잎, 측백엽, 고삼 및 감초 열수추출물의 증류액 혼합물이 적절한 용매에 효과를 나타낼 수 있는 정도의 농도로 함유되어 있는 형태로 제공될 수 있 다.The pharmaceutical composition or the cosmetic composition is a form in which the distillate mixture of golden, sewage, barberry, machi, ginkgo biloba, cypress leaf, red ginseng, and licorice hot water extract of the present invention is effective in a suitable solvent. May be provided.
본 발명의 조성물의 사용량은 연령, 병변의 정도 등의 개인 차이나 제형, 형태에 따라 적절하게 조절될 수 있으며, 본 발명의 조성물은 두피 및 모발 상태의 개선을 위한 화장품, 의약품, 또는 의약외품으로 유용하게 사용될 수 있다.The amount of the composition of the present invention can be appropriately adjusted according to individual differences, dosage forms, and forms such as age, degree of lesion, and the composition of the present invention is useful as a cosmetic, medicine, or quasi-drug for improving the scalp and hair condition. Can be used.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지 않는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention, and it will be apparent to those skilled in the art that the scope of the present invention is not to be construed as being limited by these examples.
실시예 1 : 본 발명에 따른 탈모 예방 및 양모 촉진용 조성물의 제조Example 1: Preparation of a composition for preventing hair loss and promoting wool according to the present invention
(1) 본 발명에 따른 탈모 예방 및 양모 촉진용 조성물을 획득하기 위하여, 황금 20 g, 하수오 15 g, 개자 10 g, 마치현 10 g, 은행잎 5 g, 측백엽 15 g, 고삼 15 g 및 감초 10 g을 정제수에 충분히 세척한 후, 혼합하였다. 열탕증류기에서 20L의 정제수를 이용하여 8~48시간 정도, 80~100℃로 가열하여 열수 추출물을 얻은 다음, 사용된 재료들을 제거하고, 열수 추출물을 90~100℃로 가열하면서, 4~10℃의 냉수 냉각관을 이용하여 증류액을 획득하였다. 상기 획득된 혼합 증류액을 12000 rpm에서 4℃, 30분간 원심분리하여 고형분을 제거하고, 조성물을 획득하였다.(1) In order to obtain a composition for preventing hair loss and promoting wool according to the present invention, 20 g of gold, 15 g of sewage, 10 g of barberry, 10 g of ginseng, 5 g of ginkgo biloba, 15 g of ginseng, 15 g of ginseng and 10 g of licorice After washing sufficiently with purified water, it was mixed. In hot water distillation, using 20L purified water, heated to 80 ~ 100 ℃ for 8 ~ 48 hours to obtain hot water extract, then remove the used materials and heat hot water extract to 90 ~ 100 ℃, 4 ~ 10 ℃. The distillate was obtained using the cold water cooling tube of the. The obtained mixed distillate was centrifuged at 4 ° C. for 30 minutes at 12000 rpm to remove solids, thereby obtaining a composition.
(2) 본 발명에 따른 탈모 예방 및 양모 촉진용 조성물을 획득하기 위하여, 각각 황금, 하수오, 개자, 마치현, 은행잎, 측백엽, 고삼 및 감초 재료들을 별도로 추출 및 증류하고 상기의 중량비대로 혼합하여 제조하였다.(2) In order to obtain a composition for preventing hair loss and promoting hair growth according to the present invention, gold, sewage, barberry, machi, ginkgo biloba, cypress leaves, red ginseng and licorice were separately extracted and distilled and mixed at the above weight ratio. .
구체적으로, 황금, 하수오, 개자, 마치현, 은행잎, 측백엽, 고삼 및 감초 각각 1000g을 20L의 정제수를 이용하여 8~48시간 정도, 80~100℃로 가열하여 열수 추출물을 얻었다. 추출 후, 사용된 재료들을 제거하고 열수 추출물을 90~100℃로 가열하면서, 4~10℃의 냉수 냉각관을 이용하여 각각의 증류액을 획득하였다. 획득된 각각의 증류액들을 12000 rpm에서 4℃, 30분간 원심분리하여 고형분을 제거하였다. 이들을 혼합하여 조성물 10L를 획득하기 위하여, 황금 추출물의 증류액 0.1~3.0L, 하수오 추출물의 증류액 0.1~2.5L, 개자 추출물의 증류액 0.1~2.0L, 마치현 추출물의 증류액 0.1~2.0L, 은행잎 추출물의 증류액 0.001~2.0L, 측백엽 추출물의 증류액 0.1~2.5L, 고삼 추출물의 증류액 0.1~2.5L 및 감초 추출물의 증류액 0.1~2.0L를 혼합하여 제조하였다.Specifically, 1000 g of golden, sewage, individual, machi, ginkgo biloba, baekryeop, red ginseng and licorice were heated to 80 to 100 ° C. for 8 to 48 hours using 20 L of purified water to obtain a hydrothermal extract. After extraction, the used materials were removed and the hot water extract was heated to 90-100 ° C., each distillate was obtained using a 4-10 ° C. cold water cooling tube. Each of the obtained distillates was centrifuged at 4 DEG C for 30 minutes at 12000 rpm to remove solids. In order to obtain a composition 10L by mixing them, 0.1-3.0L of distillate of golden extract, 0.1-2.5L of distillate of sewage extract, 0.1-2.0L of distillate of bastard extract, 0.1-2.0L of distillate of March extract, A distillate of 0.001 ~ 2.0L of ginkgo biloba extract, 0.1-2.5L of distillate of cypress leaf extract, 0.1-2.5L of distillate of red ginseng extract and 0.1-2.0L of distillate of licorice extract were prepared.
실험예 1: 피부세포의 증식 활성 시험Experimental Example 1 Test of Proliferation Activity of Skin Cells
본 발명에 따른 상기 조성물에 대한 피부 세포의 증식 활성을 알아보기 위하여, 인간 각질형성 세포인 HaCaT세포주(Cell Lines Service, Germany)를 1×104cells/ml의 농도로 하여 24웰 배양판에 접종하였다. 배지는 소혈청 10%를 함유한 DMEM(Dubelcco'S Modified Eagle Medium, BRL, USA)을 사용하였다. 10% FBS를 함유하는 DMEM에서 48시간 배양하여 배양용기 표면적의 25 ~ 30 % 만큼 배양되면, 실시예 1에서 제조된 조성물 0.5 % ~ 10 % 함유된 FBS-free DMEM으로 교체하여 24시간 더 배양하였다. 배양 후 3-(4,5-디메틸티아졸-2-일)-2,5-디페닐 테트 라졸리움 브롬화물 (MTT, Sigma M5655, USA) 용액 (2.5 mg/ml)을 50㎕ 첨가하고 3시간동안 추가로 배양한 후 상등액을 제거하고, 각 웰당 200 ㎕의 디메틸 설폭시드 (DMSO, Sigma D2650, USA)용액을 가한 후 20분간 교반하여 형성된 포르마잔(formazan) 결정을 녹인 다음, 100㎕ 씩을 96 웰로 취하여 Enzyme-Linked Immunosorbent Assay (ELISA)로 570 nm 에서 흡광도를 측정하였다. 세포 독성 정도는 순수한 물을 사용한 대조군의 흡광 강도를 기준으로 하기 수학식에 따라 계산하여 백분율로 표시하였다.In order to examine the proliferative activity of the skin cells for the composition according to the present invention, the human keratinocyte HaCaT cell line (Cell Lines Service, Germany) inoculated in a 24-well culture plate at a concentration of 1 × 10 4 cells / ml It was. Medium was used DMEM (Dubelcco'S Modified Eagle Medium, BRL, USA) containing 10% bovine serum. After 48 hours of incubation in DMEM containing 10% FBS and incubated for 25-30% of the surface area of the culture vessel, the cells were further incubated for 24 hours by replacing with the FBS-free DMEM containing 0.5% to 10% of the composition prepared in Example 1. . After incubation, 50 μl of 3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyl tetrazoleum bromide (MTT, Sigma M5655, USA) solution (2.5 mg / ml) was added, and 3 After further incubation for a period of time, the supernatant was removed, 200 μl of dimethyl sulfoxide (DMSO, Sigma D2650, USA) solution was added to each well, followed by stirring for 20 minutes to dissolve formazan crystals formed, followed by 100 μl. Taken into 96 wells, the absorbance was measured at 570 nm by Enzyme-Linked Immunosorbent Assay (ELISA). The degree of cytotoxicity was calculated according to the following formula based on the absorbance intensity of the control group using pure water and expressed as a percentage.
[수학식 1][Equation 1]
세포증식효과(%) = (추출물 처리시의 흡광도/대조군의 흡광도) × 100Cell proliferation effect (%) = (absorbance at the time of extract treatment / absorbance of the control group) × 100
[표 1][Table 1]
그 결과, 본 발명의 조성물은 대조군에 비하여 각각 1,78%, 3.28%, 15.69%, 32.06%로 나타나, 각각의 추출물을 함유한 실험군보다 훨씬 우수한 세포 증식 및 활성 효과를 가지는 것으로 나타났다.As a result, the composition of the present invention was found to be 1,78%, 3.28%, 15.69%, 32.06%, respectively, as compared to the control group, and showed much better cell proliferation and activity effects than the experimental group containing each extract.
실험예 2: DPPH를 이용한 항산화 시험Experimental Example 2: Antioxidant Test Using DPPH
실시예 1에서 제조된 본 발명에 따른 조성물의 항산화 효과를 확인하기 위 해, DPPH(1,1-Diphenyl-2-picrylhydrazyl, Sigma)를 이용하여 블로이스(Blois)법을 활용하여(Blois M.S., Nature 181, pp1198-1200,1958), 조성물의 라디칼 소거 효과(radical scavenging effect)를 확인하였다. DPPH는 비교적 안정한 자유 라디칼로서 보라색을 나타내며, 라디칼 상태로 존재시 517nm에서 최대 흡광도를 보이며 소거되면 흡광성을 잃기 때문에 이러한 원리를 이용하여 항산화 활성을 측정할 수 있는 방법이다.In order to confirm the antioxidant effect of the composition according to the present invention prepared in Example 1, using the Blois method using DPPH (1,1-Diphenyl-2-picrylhydrazyl, Sigma) (Blois MS, Nature 181, pp1198-1200,1958), the radical scavenging effect of the composition was confirmed. DPPH is a relatively stable free radical, which is purple, exhibits maximum absorbance at 517 nm when it is in radical state, and loses absorbance when it is eliminated. Thus, antioxidant activity can be measured using this principle.
0.2 mM DPPH 용액(Blank인 경우는 에탄올) 150 ㎕에, 실시예 1에서 제조된 조성물을 0.5~10% 농도로 함유하도록 제작하여, 이들을 각각 150 ㎕ 첨가하여 혼합하고, 실온에서 30분간 방치한 후 517 nm에서 흡광도를 측정하였으며, 이에 대한 대조군은 정제수를 이용한 경우로 설정하였다. 상기 실험군과 대조군에 대한 흡광도 측정 후, 항산화능의 정도는 순수한 물을 사용한 대조군의 흡광 강도를 기준으로 백분율로 표시하였다. 하기 수학식 2를 이용하여 자유라디칼 소거활성 효과를 구하여 그 결과를 하기 표 2에 나타내었다.150 μl of a 0.2 mM DPPH solution (ethanol in the case of Blanc) was prepared to contain 0.5-10% of the composition prepared in Example 1, and 150 μl of these were added and mixed, and the mixture was left at room temperature for 30 minutes. The absorbance was measured at 517 nm, and the control group was set to the case using purified water. After absorbance measurement for the experimental group and the control group, the degree of antioxidant capacity was expressed as a percentage based on the absorbance intensity of the control group using pure water. Using the following formula 2 to obtain the free radical scavenging activity effect is shown in Table 2 below.
[수학식 2][Equation 2]
DPPH 라디칼 소거율(%) = [(A-B)/A] × 100DPPH radical scavenging rate (%) = [(A-B) / A] × 100
(A: 대조군의 흡광도, B: 실험군을 처리하였을 때의 반응군의 흡광도)(A: absorbance of the control group, B: absorbance of the reaction group when the experimental group was treated)
그 결과는 하기 표 2와 같았다.The results were as shown in Table 2 below.
[표 2]TABLE 2
추출물 각각의 항산화 효과 보다는 황금, 하수오, 개자, 마치현, 은행잎, 측백엽, 고삼 및 감초 8종의 추출물을 혼합하여 제조한 실시예 1에 따른 조성물(혼합추출물)의 경우가 함량이 높아질수록, 항산화 효과가 증가하였으며, 특히 10% 처리시에, 가장 우수한 항산화 효과를 가지는 것으로 나타났다.Rather than the antioxidant effect of each extract, the composition (mixture extract) according to Example 1 prepared by mixing eight extracts of golden, sewage, barberry, machi, ginkgo biloba, cypress leaf, red ginseng and licorice, the higher the content, the antioxidant effect Increased, especially when treated at 10%, with the best antioxidant effect.
실험예 3 : 본 발명의 조성물의 양모 기능성 평가 동물 시험Experimental Example 3: Animal Functional Evaluation of Wool Functional Evaluation of the Composition of the Present Invention
상기 실시예 1에서 얻은 본 발명의 조성물의 효능검증을 위해 동물실험을 이용한 모발스코어 테스트를 실시하였다.A hair score test using an animal test was conducted to verify the efficacy of the composition of the present invention obtained in Example 1.
모발 성장기 유도 촉진 효과를 평가하는 동물시험 모델로서는 C57BL/6 마우스 모델을 사용하였는데, C57BL/6 마우스는 체모가 검정색이고, 자발적 탈모(spontaneous alopecia)가 일어나는 특징을 지니고 있으며, 또한 멜라노사이트(melanocyte)가 모낭에만 한정적으로 존재하고, 멜라닌(melanin) 합성이 모발 성장주기(hair growth cycle)와 잘 일치되어 피부색으로 모발의 성장주기를 판정할 수 있는 장점을 가져, 모발 성장기 유도 작용에 대한 연구에 널리 이용되고 있다.As an animal test model for evaluating hair growth induction promoting effect, the C57BL / 6 mouse model was used. Is present only in hair follicles, and the melanin synthesis matches well with the hair growth cycle, which has the advantage of determining the hair growth cycle by the color of the skin. It is used.
생후 42~56일된 마우스(C57BL/6,male)를 사용하였고, 먼저 마우스의 등 부 위의 털을 전기면도기를 이용하여 제거하고 각 마우스의 무게를 재서 몸무게가 골고루 분산이 되도록 10 마리씩 나누었다. 하루 동안 적응 기간을 두고 다음날부터 제모 부위에 대조군, 5% 미녹시딜 및 실시예 1에 따른 탈모 예방 및 양모 생장 촉진 조성물을 도포하였으며, 이때 대조군으로는 35% 에탄올을 사용하였고, 상기 실시예 1에 따른 탈모 예방 및 양모 생장 촉진 조성물의 농축 고형물을 35% 에탄올로 희석하여 사용하였다. 마우스 개체 당 등 부위에 1일 1회, 100 ㎕씩을 15일간 도포하여 성장기 유도 촉진 작용을 관찰하였다.42-56 days old mice (C57BL / 6, male) were used. First, the hair on the back of the mouse was removed using an electric razor, and each mouse was weighed and divided into 10 pieces so that the weight was evenly distributed. After the adaptation period for one day, the hair removal site was coated with a control group, 5% minoxidil, and hair loss prevention and wool growth promoting composition according to Example 1, wherein 35% ethanol was used as a control group. The concentrated solid of the hair loss prevention and wool growth promoting composition was used diluted with 35% ethanol. 100 µl each was applied to the back of the mouse per day for 15 days to observe the growth phase induction promoting action.
도 1에 나타난 바와 같이, 3일 및 8일이 경과한 후에는 미녹시딜 처리군 및 대조군에 비해 본 발명에 따른 조성물 처리군이 발모 촉진 효과가 우수하였으며, 15일 경과후에는, 본 발명에 따른 조성물을 처리한 마우스의 경우, 거의 완벽하게 탈모된 부위가 회복되었다.As shown in FIG. 1, after 3 days and 8 days, the composition treatment group according to the present invention was superior to the minoxidil treatment group and the control group, and after 15 days, the composition according to the present invention. In the case of the mice treated with, the hair loss site was recovered almost completely.
실험예 4 : 본 발명의 조성물의 양모 기능성 평가 시험Experimental Example 4: Wool functional evaluation test of the composition of the present invention
동물실험에서 일차적으로 효능을 확인한 본 발명 복합 조성물을 가지고 상품화할 수 있는 기본 제형을 통해 여성 및 남성 탈모증을 가진 자를 선정하여 소규모 임상실험을 실시하였다. 피험자는 30~60세까지의 탈모증이 있는 성인남녀 총 20명(남성 15명, 여성 5명)을 대상으로 2그룹으로 나누어 1일 1회, 1회에 5 ml씩 약국에 시판되는 미녹시딜 5% 제품(현대약품제조)과 상기 실시예 1에 따라 얻은 본 발명 조성물(실시예 1에 따른 탈모 예방 및 양모 생장 촉진 조성물의 농축 고형물을 35% 에탄올로 희석하여 사용)로 제조된 액상 토닉을 가지고 3개월간 탈모부위에 도포하여 그 결과를 관찰하였다.Small scale clinical trials were conducted by selecting female and male alopecia patients through the basic formulations that can be commercialized with the present invention composite compositions that were primarily confirmed in animal experiments. Subjects were divided into two groups for 20 adult men and women with hair loss ranging from 30 to 60 years old (15 males, 5 females). 5% of minoxidil sold at the pharmacy 5 ml once a day Having a liquid tonic prepared from a product (prepared in modern medicine) and the composition of the present invention obtained according to Example 1 (concentrated solids of the hair loss prevention and wool growth promoting composition according to Example 1 diluted with 35% ethanol) 3 It was applied to the bald area for months and the result was observed.
효과의 판정은 세발 시 일일 평균 탈모량, 육안판정소견 및 자각증상 개선 정도를 평가척도로써 5단계로 평가하고 종합적인 개선도를 상기 평가 척도의 평균으로 하였는데, 그 점수는 5점 만점으로 단계에 따라 1점 단위로 부여하였는데, 하기 표 3과 같다. 실험군은 미녹시딜 5%군과 본 발명의 조성물군으로 나누어 실시하였다.The evaluation of the effect was performed by five stages of evaluation of daily hair loss, visual judgment, and improvement of subjective symptoms during trituration, and the overall improvement was taken as the average of the evaluation scales. According to one point unit, as shown in Table 3. The experimental group was divided into the minoxidil 5% group and the composition group of the present invention.
[표 3] 소규모 임상실험시 사용되는 점수 척도[Table 3] Score scale used in small clinical trials
[표 4] 소규모 임상실험 결과[Table 4] Small scale clinical trial results
상기 표 3 및 표 4로부터 알 수 있듯이, 소규모 임상실험 결과, 미녹시딜 처리군에 비해 본 발명의 조성물 처리군은 육안판정, 자각증상, 세발 시 탈모수에 있어서 45 ~ 90%의 탈모 개선효과를 보였다. 종합적인 개선도를 산정해보면 평균 70 %의 개선 효과가 있는 것으로 나타났다.As can be seen from Table 3 and Table 4, as a result of small-scale clinical trials, the composition-treated group of the present invention showed 45 to 90% improvement in hair loss during visual judgment, subjective symptoms, and hair loss compared to the minoxidil-treated group. . Comprehensive improvement was found to have an average 70% improvement.
도 1은 본 발명에 따른 조성물의 효능검증을 위해 동물실험을 이용한 모발스코어 테스트를 실시한 결과이다.1 is a result of a hair score test using an animal experiment for the validation of the composition according to the present invention.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090064244A KR101133785B1 (en) | 2009-07-13 | 2009-07-13 | Composition for Preventing Hair Loss and Promoting Hair Growth Containing Scultellaria baicallensis and Method of Preparing the Same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090064244A KR101133785B1 (en) | 2009-07-13 | 2009-07-13 | Composition for Preventing Hair Loss and Promoting Hair Growth Containing Scultellaria baicallensis and Method of Preparing the Same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20110006549A KR20110006549A (en) | 2011-01-20 |
KR101133785B1 true KR101133785B1 (en) | 2012-04-13 |
Family
ID=43613374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090064244A KR101133785B1 (en) | 2009-07-13 | 2009-07-13 | Composition for Preventing Hair Loss and Promoting Hair Growth Containing Scultellaria baicallensis and Method of Preparing the Same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101133785B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210004328A (en) * | 2019-07-04 | 2021-01-13 | 주식회사 코리아나화장품 | Cosmetic composition comprising mixed extracts of cnidium officinale and scutellaria baicalensis or compounds seperated from thereof for alleiviating acne and dandruff |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101348006B1 (en) * | 2011-08-26 | 2014-01-13 | 윤태민 | Topical preparations for hair growth |
KR101970503B1 (en) * | 2012-02-15 | 2019-04-19 | (주)아모레퍼시픽 | Composition containing Scutellaria baicalensis extract and vinegars for scalp or hair |
CN102697938B (en) * | 2012-06-29 | 2013-07-31 | 乌鲁木齐哈孜巴义生发技术研究所(有限公司) | Natural hair growth promoting liquid and preparation method thereof |
KR102114133B1 (en) | 2014-10-06 | 2020-05-22 | (주)아모레퍼시픽 | Composition for hair loss prevention or hair growth stimulation comprising scutellaria alpina extract |
KR20240053102A (en) | 2022-10-14 | 2024-04-24 | (주) 비에스티 | A Composition Containing a Scutellaria Baicalensis Root Extract and an Ecklonia Cava Extract for Preventing an Alopecia |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070052248A (en) * | 2007-02-08 | 2007-05-21 | 이태희 | The composition for natural hair growth promoting agents |
KR20080025466A (en) * | 2006-09-18 | 2008-03-21 | 루크제약 주식회사 | Composition of stops the hair from falling out and the process |
KR20080032127A (en) * | 2005-08-12 | 2008-04-14 | 켄지 코노 | Agent for hair growth |
-
2009
- 2009-07-13 KR KR1020090064244A patent/KR101133785B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080032127A (en) * | 2005-08-12 | 2008-04-14 | 켄지 코노 | Agent for hair growth |
KR20080025466A (en) * | 2006-09-18 | 2008-03-21 | 루크제약 주식회사 | Composition of stops the hair from falling out and the process |
KR20070052248A (en) * | 2007-02-08 | 2007-05-21 | 이태희 | The composition for natural hair growth promoting agents |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210004328A (en) * | 2019-07-04 | 2021-01-13 | 주식회사 코리아나화장품 | Cosmetic composition comprising mixed extracts of cnidium officinale and scutellaria baicalensis or compounds seperated from thereof for alleiviating acne and dandruff |
KR102282645B1 (en) * | 2019-07-04 | 2021-07-28 | 주식회사 코리아나화장품 | Cosmetic composition comprising mixed extracts of cnidium officinale and scutellaria baicalensis or compounds seperated from thereof for alleiviating acne and dandruff |
Also Published As
Publication number | Publication date |
---|---|
KR20110006549A (en) | 2011-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101743197B1 (en) | The manufacturing method of shampoo composition for caring scalp and promoting hair growth, and shampoo composition thereof | |
KR101150556B1 (en) | Composition for Preventing Hair Loss and Promoting Hair Growth | |
KR100960054B1 (en) | Hair cosmetic composition for improving stste of scalp and preventing fall-out of hair | |
KR100701606B1 (en) | The cosmetic composition with a herb medicine extract and the producing method thereof | |
KR101445553B1 (en) | Composition with effect on hair growth | |
KR101387308B1 (en) | Skin whitening composition by using of dendropanax morbifera ferment extract | |
KR101049776B1 (en) | Cosmetic composition for prevention of depilation and improvement of hair growth, the manufacturing method the same and composition for improving condition of hair containing thereof | |
KR101133785B1 (en) | Composition for Preventing Hair Loss and Promoting Hair Growth Containing Scultellaria baicallensis and Method of Preparing the Same | |
KR101953779B1 (en) | Method for producting chinese medicine composition and shampoo | |
KR102326660B1 (en) | Compositions for preventing hair loss, promoting hair growth and increasing hair thickness comprising herbal extracts | |
KR101787531B1 (en) | Composition for preventing hair loss comprising extracts of crude drug complex | |
KR101739229B1 (en) | Composition for Preventing Hair Loss and Promoting Hair Growth and A method for manufacturing thereof | |
KR20200137526A (en) | Composition for preventing hair loss and promoting hair growth | |
KR20090012565A (en) | Compositions for preventing hair loss or stimulating hair growth containing natural extract | |
KR101516536B1 (en) | Composition for Preventing Hair Loss and Promoting Hair Growth and A method for manufacturing thereof | |
KR20170137544A (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR100564108B1 (en) | Cosmetic composition comprising plant extract having anti-aging effect | |
KR100664400B1 (en) | Composition for preventing the hair from falling out | |
KR20170137552A (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR100970126B1 (en) | Method of preparing?compositions for preventing depilation and for promoting hair-growing | |
KR102030275B1 (en) | Hair cleanser composition | |
KR20170136930A (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR20170136912A (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR20170136919A (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR20170137412A (en) | Composition for improving skin condition comprising herb extracts mixture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20160330 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20170323 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20180313 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20190328 Year of fee payment: 8 |